
<!DOCTYPE html>
<html lang="en">
<head>
    <meta charset="UTF-8">
    <title>Document Content</title>
    <style>
        body { font-family: Arial, sans-serif; line-height: 1.6; max-width: 900px; margin: auto; padding: 20px; }
        table { border-collapse: collapse; width: 100%; margin-top: 20px; margin-bottom: 20px; }
        th, td { border: 1px solid #cccccc; text-align: left; padding: 8px; font-size: 12px; }
        tr:nth-child(even) { background-color: #f9f9f9; }
        th { background-color: #3366CC; color: white; font-weight: bold; }
        h2 { color: #4F81BD; border-bottom: 2px solid #4F81BD; padding-bottom: 5px;}
        p { margin-block-start: 0.5em; margin-block-end: 0.5em; }
    </style>
</head>
<body>
    <p style="font-size: small; color: grey;"><i>Page 30 of 123</i></p>
<p style="font-size: small; color: grey;"><i>Document</i></p>
<p style="font-size: small; color: grey;"><i>AKORN_10k_030.pdf</i></p>
<h2>Item 6. Selected Financial Data</h2>
<p>The following table sets forth selected summary historical financial data. We have prepared this table using our consolidated financial statements for the five years ended December 31, 2017. Our consolidated financial statements upon which the selected summary historical financial data is derived were audited by BDO USA, LLP (&quot;BDO&quot;), independent registered public accounting firm, during each of the five years ended December 31, 2017, 2016, 2015, 2014 and 2013. This summary should be read in conjunction with our audited Consolidated Financial Statements and Notes thereto, and &quot;Item 7 - Management&#x27;s Discussion and Analysis of Financial Condition and Results of Operations&quot; and other financial information included herein.</p>

<table>
	<tr>
		<th rowspan="2"></th>
		<th colspan="5">Years Ended December 31,</th>
	</tr>
	<tr>
		<th>2017</th>
		<th>2016</th>
		<th>2015 (1)</th>
		<th>2014 (1)</th>
		<th>2013</th>
	</tr>
	<tr>
		<td>(In thousands, except per share data)</td>
		<td></td>
		<td></td>
		<td></td>
		<td></td>
		<td></td>
	</tr>
	<tr>
		<td>Revenues</td>
		<td>$ 841,045</td>
		<td>$ 1,116,843</td>
		<td>$ 985,076</td>
		<td>$ 555,048</td>
		<td>$ 317,711</td>
	</tr>
	<tr>
		<td>Gross profit</td>
		<td>433,147</td>
		<td>674,271</td>
		<td>596,012</td>
		<td>261,360</td>
		<td>171,904</td>
	</tr>
	<tr>
		<td>Operating (loss) income</td>
		<td>(17,656)</td>
		<td>327,571</td>
		<td>294,611</td>
		<td>60,816</td>
		<td>88,204</td>
	</tr>
	<tr>
		<td>Interest expense, net, amortization of deferred financing costs and other non-operating income (expense), net</td>
		<td>(41,542)</td>
		<td>(56,271)</td>
		<td>(62,455)</td>
		<td>(35,474)</td>
		<td>(5,309)</td>
	</tr>
	<tr>
		<td>Pretax (loss) income from continuing operations</td>
		<td>(59,198)</td>
		<td>271,300</td>
		<td>232,156</td>
		<td>25,342</td>
		<td>82,895</td>
	</tr>
	<tr>
		<td>Income tax (benefit) provision from continuing operations</td>
		<td>(34,648)</td>
		<td>87,057</td>
		<td>81,358</td>
		<td>10,954</td>
		<td>30,533</td>
	</tr>
	<tr>
		<td>(Loss) income from continuing operations</td>
		<td>$ (24,550)</td>
		<td>$ 184,243</td>
		<td>$ 150,798</td>
		<td>$ 14,388</td>
		<td>$ 52,362</td>
	</tr>
	<tr>
		<td>Weighted average shares outstanding:</td>
		<td></td>
		<td></td>
		<td></td>
		<td></td>
		<td></td>
	</tr>
	<tr>
		<td>Basic</td>
		<td>124,790</td>
		<td>122,869</td>
		<td>116,980</td>
		<td>103,480</td>
		<td>96,181</td>
	</tr>
	<tr>
		<td>Diluted</td>
		<td>124,790</td>
		<td>125,801</td>
		<td>125,762</td>
		<td>109,588</td>
		<td>113,898</td>
	</tr>
	<tr>
		<td>PER SHARE:</td>
		<td></td>
		<td></td>
		<td></td>
		<td></td>
		<td></td>
	</tr>
	<tr>
		<td>Equity, per diluted share</td>
		<td>$ 6.66</td>
		<td>$ 6.51</td>
		<td>$ 4.94</td>
		<td>$ 3.25</td>
		<td>$ 2.28</td>
	</tr>
	<tr>
		<td>(Loss) income from continuing operations per share:</td>
		<td></td>
		<td></td>
		<td></td>
		<td></td>
		<td></td>
	</tr>
	<tr>
		<td>Basic</td>
		<td>$ (0.20)</td>
		<td>$ 1.50</td>
		<td>$ 1.29</td>
		<td>$ 0.14</td>
		<td>$ 0.54</td>
	</tr>
	<tr>
		<td>Diluted</td>
		<td>$ (0.20)</td>
		<td>$ 1.47</td>
		<td>$ 1.22</td>
		<td>$ 0.13</td>
		<td>$ 0.46</td>
	</tr>
	<tr>
		<td>Share Price: High</td>
		<td>$ 34.00</td>
		<td>$ 39.46</td>
		<td>$ 57.10</td>
		<td>$ 45.25</td>
		<td>$ 26.16</td>
	</tr>
	<tr>
		<td>Low</td>
		<td>$ 17.74</td>
		<td>$ 17.57</td>
		<td>$ 19.08</td>
		<td>$ 20.52</td>
		<td>$ 12.44</td>
	</tr>
	<tr>
		<td>BALANCE SHEET DATA:</td>
		<td></td>
		<td></td>
		<td></td>
		<td></td>
		<td></td>
	</tr>
	<tr>
		<td>Current assets</td>
		<td>$ 730,151</td>
		<td>$ 685,811</td>
		<td>$ 708,132</td>
		<td>$ 437,750</td>
		<td>$ 169,108</td>
	</tr>
	<tr>
		<td>Net property, plant &amp; equipment</td>
		<td>$ 313,418</td>
		<td>$ 238,404</td>
		<td>$ 179,614</td>
		<td>$ 144,196</td>
		<td>$ 82,108</td>
	</tr>
	<tr>
		<td>Total assets</td>
		<td>$ 1,909,511</td>
		<td>$ 1,973,720</td>
		<td>$ 2,042,545</td>
		<td>$ 1,832,150</td>
		<td>$ 426,129</td>
	</tr>
	<tr>
		<td>Current liabilities</td>
		<td>$ 171,089</td>
		<td>$ 175,555</td>
		<td>$ 231,376</td>
		<td>$ 150,853</td>
		<td>$ 61,245</td>
	</tr>
	<tr>
		<td>Long-term obligations, less current installments</td>
		<td>$ 907,177</td>
		<td>$ 978,981</td>
		<td>$ 1,189,604</td>
		<td>$ 1,324,990</td>
		<td>$ 104,704</td>
	</tr>
	<tr>
		<td>Shareholders&#x27; equity</td>
		<td>$ 831,245</td>
		<td>$ 819,184</td>
		<td>$ 621,565</td>
		<td>$ 356,307</td>
		<td>$ 260,180</td>
	</tr>
	<tr>
		<td>CASH FLOW DATA:</td>
		<td></td>
		<td></td>
		<td></td>
		<td></td>
		<td></td>
	</tr>
	<tr>
		<td>Cash provided by operating activities</td>
		<td>$ 249,264</td>
		<td>$ 167,759</td>
		<td>$ 297,648</td>
		<td>$ 40,442</td>
		<td>$ 57,326</td>
	</tr>
	<tr>
		<td>Cash used in investing activities</td>
		<td>$ (90,555)</td>
		<td>$ (72,922)</td>
		<td>$ (53,718)</td>
		<td>$ (966,874)</td>
		<td>$ (66,874)</td>
	</tr>
	<tr>
		<td>Cash provided by (used in) financing activities</td>
		<td>$ 7,594</td>
		<td>$ (240,333)</td>
		<td>$ 31,908</td>
		<td>$ 963,116</td>
		<td>$ 3,118</td>
	</tr>
	<tr>
		<td>Effect of changes in exchange rates</td>
		<td>$ 1,044</td>
		<td>$ 2</td>
		<td>$ (251)</td>
		<td>$ (183)</td>
		<td>$ (173)</td>
	</tr>
	<tr>
		<td>Increase/(decrease) in cash and cash equivalents</td>
		<td>$ 167,347</td>
		<td>$ (145,494)</td>
		<td>$ 275,587</td>
		<td>$ 36,501</td>
		<td>$ (6,603)</td>
	</tr>
</table>
<p style="font-size: small; color: grey;"><i>30</i></p>
<p style="font-size: small; color: grey;"><i>file://usmdcvdi003.us.kworld.kpmg.com/GDC_Ops/Operations/Gayathri%20Krishnan/RPA%20Phase%20II/Kiran/HealthCare/ ... 7/23/2018</i></p>

</body>
</html>
